Overview

The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial

Status:
Completed
Trial end date:
2022-12-06
Target enrollment:
0
Participant gender:
Female
Summary
Will follow up umblical artery Doppler indices for pregnancies with iugr taking placebo and oral isosorbide mononitrate to study its efficacy on the intrauterine growth restricted fetuses
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams University
Treatments:
Isosorbide
Criteria
Inclusion Criteria:

- age : 18-34 BMI: 18-30 Singleton pregnancy Gestational age between 28-30 Criteria of
IUGR

Exclusion Criteria:

Had known or suspected chromosomal or structural anomaly Had a condition which will require
delivery Multiple pregnancy

-